Type 1 Diabetes

Two studies show use of sensor implanted under skin that continuously monitors glucose levels resulted in improved levels in T1 patients who inject insulin multiple times a day.

Barrier means more work including monitoring more often and making more adjustments.

Device automatically monitors blood glucose levels and delivers insulin when appropriate for people age 14 years and older who have type 1 diabetes.

For those healthcare providers who treat diabetes with any kind of regularity, it has become increasingly obvious that several of our patients fall outside the current diabetes classification system. With individualization of patient care being the new focus, it can be challenging to accomplish this, when certain diabetic individuals don’t “conform” to the current definitions.

Scientists believe drug commonly prescribed for T2 could be routinely taken by T1 patients.

Could GLP-1 inhibitors be a useful adjunct therapy in type I diabetes?

In part one of this exclusive interview, Dr. Robert Geho discusses the essential role of the liver in metabolizing insulin, and asks why we hear about the artificial pancreas all the time, but never hear anyone talk about an artificial liver?

In this exclusive interview transcript, Dr. Stanley Schwartz discusses the proposed new diabetes classification, which seeks to not only just classify but to help in determining what type of treatment might be best for that patient.

A team of researchers at the University of Wisconsin School of Medicine and Public Health has identified the genetic cause for a rare syndrome in children with poorly controlled type 1 diabetes.

In part 3 of this exclusive interview, Dr. Faustman discusses how a cure based on the inexpensive BCG vaccine could permanently change type 1 treatment, and whether results could also apply to type 2.